ECSP972158A - REPLACED INDAZOLE ANALOGS - Google Patents
REPLACED INDAZOLE ANALOGSInfo
- Publication number
- ECSP972158A ECSP972158A ECSP972158A ECSP972158A EC SP972158 A ECSP972158 A EC SP972158A EC SP972158 A ECSP972158 A EC SP972158A EC SP972158 A ECSP972158 A EC SP972158A
- Authority
- EC
- Ecuador
- Prior art keywords
- replaced
- indazole analogs
- compounds
- formula
- acceptable salts
- Prior art date
Links
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a compuestos de fórmula I: (gráfico) y sales farmacéuticamente aceptables de los mismos, en los que R, R1 y R2 son tal como se define en la presente. La invención está además relacionada con composiciones farmacéuticas que los O contienen, y a procedimientos de uso de los compuestos de fórmula I, o sales aceptables de los mismos, para la inhibición de la fosfodiesterasa (PDE) tipo IV o de la producción de factor de necrosis tumoral (TNF) en un mamífero.The invention relates to compounds of formula I: (graph) and pharmaceutically acceptable salts thereof, wherein R, R1 and R2 are as defined herein. The invention is further related to pharmaceutical compositions containing the O, and to methods of using the compounds of formula I, or acceptable salts thereof, for the inhibition of type IV phosphodiesterase (PDE) or the production of necrosis factor tumor (TNF) in a mammal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972158 ECSP972158A (en) | 1997-06-23 | 1997-06-23 | REPLACED INDAZOLE ANALOGS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972158 ECSP972158A (en) | 1997-06-23 | 1997-06-23 | REPLACED INDAZOLE ANALOGS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972158A true ECSP972158A (en) | 1998-04-24 |
Family
ID=42042989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972158 ECSP972158A (en) | 1997-06-23 | 1997-06-23 | REPLACED INDAZOLE ANALOGS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972158A (en) |
-
1997
- 1997-06-23 EC ECSP972158 patent/ECSP972158A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR007456A1 (en) | COMPOUNDS DERIVED FROM SUBSTITUTED INDAZOL AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
| CO4650038A1 (en) | SUBSTITUTED INDAZOL DERIVATIVES AND RELATED COMPOUNDS | |
| PA8437301A1 (en) | INDAZOL DERIVATIVES | |
| DE69827236D1 (en) | Matrix-metalloproteinase-hemmer | |
| ES2094721T3 (en) | ANALOGS OF THE CAMPTOTECINE SOLUBLE IN WATER. | |
| AR027437A1 (en) | PURINA DERIVATIVES | |
| BR0014137A (en) | Compound, method for inhibiting aurora 2 kinase in a warm-blooded animal, use of a compound, and pharmaceutical composition | |
| AR029216A1 (en) | NON-PEPTIDIC INHIBITING COMPOUNDS OF THE VLA-4 DEPENDENT CELL UNION IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES; PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE | |
| DK1678166T3 (en) | protein kinase inhibitors | |
| EA200100766A1 (en) | QUINOLIN-2-ON-SUBSTITUTED HETEROAARYNE DERIVATIVES USED AS ANTI-TUMOR AGENTS | |
| AR011116A1 (en) | N-HYDROXY-BETA-SULFONIL PROPIONAMIDE DERIVED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING IT | |
| UY26968A1 (en) | THERAPEUTIC AGENTS | |
| ES2196377T3 (en) | NAFTIRIDINE DERIVATIVES | |
| AR041184A1 (en) | DERIVATIVES OF BENZOPIRANONAS, INHIBITORS OF CYCLINE DEPENDENT KINES AND THEIR USE | |
| RU94040390A (en) | Derivatives of vinyleneazaindole, method of their synthesis, pharmaceutical composition | |
| DK452682A (en) | UNIDENTIFIED IMIDAZOLD DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| AR012436A1 (en) | 4-AMINOPIRIDE [2,3-D] PIRIMIDINE 5,7-DISSTITUTED COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM, THE USE OF THE SAME FOR LAMANUFACTURE OF MEDICINES, A PROCEDURE FOR THEIR PREPARATION. | |
| ES2172376B1 (en) | NEW DERIVATIVES OF ISOQUINOLEINS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| ECSP972158A (en) | REPLACED INDAZOLE ANALOGS | |
| ECSP972246A (en) | INDAZOL DERIVATIVES | |
| MX9405111A (en) | NEW DERIVATIVES OF (1-PHENYL-1-HETEROCICLIL) METHANOL AND (1-PHENYL-1-HETEROCICLIL-METHYLAMINE). | |
| ECSP972102A (en) | SUBSTITUTED INDAZOL DERIVATIVES AND RELATED COMPOUNDS | |
| EA200600022A1 (en) | APPLICATION OF DERIVATIVE BICYCLO [2.2.1] HEPTANA TO PREPARE NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS | |
| CO5040081A1 (en) | NEW PHARMACEUTICAL VITY COMPOUNDS | |
| UY28119A1 (en) | NEW DERIVATIVES CONTAINING PHOSPHORUS |